Pharmacy Innovations 2023-02-01 Health serious FDA
Health · FDA · Recall #FDA-D-0220-2023
METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE;… Recall
Issued February 1, 2023 · Pharmacy Innovations
In February 2023, Pharmacy Innovations recalled the METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE;…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
What you should do
- 1 Stop using METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE;… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pharmacy Innovations to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pharmacy Innovations
- Category
- Health
- Recall date
- February 1, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0220-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Pharmacy Innovations has 41 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.